Changes in circadian gene expression, in particular CLOCK have been previously reported in AML, ALL and CML patients when compared to healthy individuals [9, 10, 11]. The gene discussed is CLOCK; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.